Developing a complete pharmacology for AMPA receptors: A perspective on subtype-selective ligands

Bioorganic and Medicinal Chemistry

Volumn 18, Issue 4, 2010, Pages 1381-1387

  Fleming, James J ^a   England, Pamela M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Agonist; Allosteric modulator; AMPA receptor; Antagonist; Polyamine toxin; Pore blocker; Subtype selective ligand

Indexed keywords

1 (4 AMINOPHENYL) 3,4 DIHYDRO 4 METHYL 3 METHYLCARBAMOYL 7,8 METHYLENEDIOXY 5H 2,3 BENZODIAZEPINE; 1 (4 AMINOPHENYL) 4 METHYL 7,8 METHYLENEDIOXY 5H 2,3 BENZODIAZEPINE; 6 CYANO 7 NITRO 2,3 QUINOXALINEDIONE; 6 NITRO 7 SULFAMOYLBENZO[F]QUINOXALINE 2,3 DIONE; 6 QUINOXALINECARBOXYLIC ACID PIPERIDIDE; ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; AMPA RECEPTOR; ANIRACETAM; ANTIMIGRAINE AGENT; ARGIOTOXIN 636; CP 465 022; CX 614; CYCLOTHIAZIDE; GLUTAMIC ACID; IFENPRODIL; KAINIC ACID; N [2 [4 (4 CYANOPHENYL)PHENYL]PROPYL] 2 PROPANESULFONAMIDE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; PHILANTHOTOXIN; PHILANTHOTOXIN 343; PHILANTHOTOXIN 74; PHTHALAZINE DERIVATIVE; SULFONAMIDE; SYM 2207; TALAMPANEL; TEZAMPANEL; UNCLASSIFIED DRUG;

ALLOSTERISM; ALZHEIMER DISEASE; BINDING SITE; COMPETITIVE INHIBITION; DRUG STRUCTURE; EPILEPSY; HUMAN; LIGAND BINDING; MAMMAL; MENTAL DISEASE; MIGRAINE; NERVOUS SYSTEM; NONHUMAN; RECEPTOR BLOCKING; SHORT SURVEY; SYNAPSE; SYNAPTIC TRANSMISSION;

ALLOSTERIC REGULATION; ANIMALS; BINDING SITES; LIGANDS; RECEPTORS, AMPA;

MAMMALIA;

EID: 75849158881     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmc.2009.12.072     Document Type: Short Survey

References (101)

1. Palmer C.L., Cotton L., and Henley J.M. Pharmacol. Rev. 57 (2005) 253
2. Hollmann M., and Heinemann S. Annu. Rev. Neurosci. 17 (1994) 31
3. Dingledine R., Borges K., Bowie D., and Traynelis S.F. Pharmacol. Rev. 51 (1999) 7
4. Shepherd J.D., and Huganir R.L. Annu. Rev. Cell Dev. Biol. 23 (2007) 613
5. Kessels H.W., and Malinow R. Neuron 61 (2009) 340
6. Shi S., Hayashi Y., Esteban J.A., and Malinow R. Cell 105 (2001) 331
7. Liu S.Q., and Cull-Candy S.G. Nature 405 (2000) 454
8. Conrad K.L., Tseng K.Y., Uejima J.L., Reimers J.M., Heng L.J., Shaham Y., Marinelli M., and Wolf M.E. Nature 454 (2008) 118
9. Almeida C.G., Tampellini D., Takahashi R.H., Greengard P., Lin M.T., Snyder E.M., and Gouras G.K. Neurobiol. Dis. 20 (2005) 187
10. Meador-Woodruff J.H., and Healy D.J. Brain Res. Brain Res. Rev. 31 (2000) 288
11. Sans N., Vissel B., Petralia R.S., Wang Y.X., Chang K., Royle G.A., Wang C.Y., O'Gorman S., Heinemann S.F., and Wenthold R.J. J. Neurosci. 23 (2003) 9367
12. Wenthold R.J., Petralia R.S., Blahos II J., and Niedzielski A.S. J. Neurosci. 16 (1996) 1982
13. Geiger J.R., Melcher T., Koh D.S., Sakmann B., Seeburg P.H., Jonas P., and Monyer H. Neuron 15 (1995) 193
14. Greger I.H., Khatri L., Kong X., and Ziff E.B. Neuron 40 (2003) 763
15. Jonas P., and Burnashev N. Neuron 15 (1995) 987
16. Washburn M.S., Numberger M., Zhang S., and Dingledine R. J. Neurosci. 17 (1997) 9393
17. Mayer M.L. Nature 440 (2006) 456
18. Armstrong N., and Gouaux E. Neuron 28 (2000) 165
19. Jin R., Banke T.G., Mayer M.L., Traynelis S.F., and Gouaux E. Nat. Neurosci. 6 (2003) 803
20. Jin R., Clark S., Weeks A.M., Dudman J.T., Gouaux E., and Partin K.M. J. Neurosci. 25 (2005) 9027
21. Sun Y., Olson R., Horning M., Armstrong N., Mayer M., and Gouaux E. Nature 417 (2002) 245
22. Balannik V., Menniti F.S., Paternain A.V., Lerma J., and Stern-Bach Y. Neuron 48 (2005) 279
23. Bahring R., and Mayer M.L. J. Physiol. 509 Pt 3 (1998) 635
24. Passafaro M., Nakagawa T., Sala C., and Sheng M. Nature 424 (2003) 677
25. Williams K. Mol. Pharmacol. 44 (1993) 851
26. Auberson Y.P., Allgeier H., Bischoff S., Lingenhoehl K., Moretti R., and Schmutz M. Bioorg. Med. Chem. Lett. 12 (2002) 1099
27. Kew J.N., and Kemp J.A. Psychopharmacology (Berl) 179 (2005) 4
28. Keinanen K., Wisden W., Sommer B., Werner P., Herb A., Verdoorn T.A., Sakmann B., and Seeburg P.H. Science 249 (1990) 556
29. Strange M., Brauner-Osborne H., and Jensen A.A. Comb. Chem. High Throughput Screening 9 (2006) 147
30. Banke T.G., Schousboe A., and Pickering D.S. J. Neurosci. Res. 49 (1997) 176
31. Coquelle T., Christensen J.K., Banke T.G., Madsen U., Schousboe A., and Pickering D.S. NeuroReport 11 (2000) 2643
32. Bjerrum E.J., Kristensen A.S., Pickering D.S., Greenwood J.R., Nielsen B., Liljefors T., Schousboe A., Brauner-Osborne H., and Madsen U. J. Med. Chem. 46 (2003) 2246
33. Jensen A.A., Christesen T., Bolcho U., Greenwood J.R., Postorino G., Vogensen S.B., Johansen T.N., Egebjerg J., Brauner-Osborne H., and Clausen R.P. J. Med. Chem. 50 (2007) 4177
34. Patneau D.K., Mayer M.L., Jane D.E., and Watkins J.C. J. Neurosci. 12 (1992) 595
35. Jane D.E., Hoo K., Kamboj R., Deverill M., Bleakman D., and Mandelzys A. J. Med. Chem. 40 (1997) 3645
36. Greenwood J.R., Mewett K.N., Allan R.D., Martin B.O., and Pickering D.S. Neuropharmacology 51 (2006) 52
37. Banke T.G., Greenwood J.R., Christensen J.K., Liljefors T., Traynelis S.F., Schousboe A., and Pickering D.S. J. Neurosci. 21 (2001) 3052
38. Hogner A., Kastrup J.S., Jin R., Liljefors T., Mayer M.L., Egebjerg J., Larsen I.K., and Gouaux E. J. Mol. Biol. 322 (2002) 93
39. Gill A., Birdsey-Benson A., Jones B.L., Henderson L.P., and Madden D.R. Biochemistry 47 (2008) 13831
40. Sobolevsky A.I., Rosconi M.P., and Gouaux E. Nature 462 (2009) 745
41. Wyllie D.J., and Chen P.E. Br. J. Pharmacol. 150 (2007) 541
42. Stein E., Cox J.A., Seeburg P.H., and Verdoorn T.A. Mol. Pharmacol. 42 (1992) 864
43. Morrow J.A., Maclean J.K., and Jamieson C. Curr. Opin. Drug Discovery Dev. 9 (2006) 571
44. Partin K.M., Patneau D.K., Winters C.A., Mayer M.L., and Buonanno A. Neuron 11 (1993) 1069
45. Partin K.M., Patneau D.K., and Mayer M.L. Mol. Pharmacol. 46 (1994) 129
46. Partin K.M., Fleck M.W., and Mayer M.L. J. Neurosci. 16 (1996) 6634
47. Johansen T.H., Chaudhary A., and Verdoorn T.A. Mol. Pharmacol. 48 (1995) 946
48. Weigand E., and Keller B.U. Eur. J. Neurosci. 10 (1998) 64
49. Miu P., Jarvie K.R., Radhakrishnan V., Gates M.R., Ogden A., Ornstein P.L., Zarrinmayeh H., Ho K., Peters D., Grabell J., Gupta A., Zimmerman D.M., and Bleakman D. Neuropharmacology 40 (2001) 976
50. Sekiguchi M., Fleck M.W., Mayer M.L., Takeo J., Chiba Y., Yamashita S., and Wada K. J. Neurosci. 17 (1997) 5760
51. Partin K.M., Bowie D., and Mayer M.L. Neuron 14 (1995) 833
52. Pelletier J.C., Hesson D.P., Jones K.A., and Costa A.M. J. Med. Chem. 39 (1996) 343
53. Gitto R., Barreca M.L., De Luca L., De Sarro G., Ferreri G., Quartarone S., Russo E., Constanti A., and Chimirri A. J. Med. Chem. 46 (2003) 197
54. Ruel J., Guitton M.J., and Puell J.L. CNS Drug Rev. 8 (2002) 235
55. Partin K.M., and Mayer M.L. Mol. Pharmacol. 49 (1996) 142
56. Cotton J.L., and Partin K.M. Neuropharmacology 39 (2000) 21
57. Cokic B., and Stein V. Neuropharmacology 54 (2008) 1062
58. Grishin E.V., Volkova T.M., Arsen'ev A.S., Reshetova O.S., and Onoprienko V.V. Bioorg. Khim. 12 (1986) 1121
59. Bateman A., Boden P., Dell A., Duce I.R., Quicke D.L., and Usherwood P.N. Brain Res. 339 (1985) 237
60. Eldefrawi A.T., Eldefrawi M.E., Konno K., Mansour N.A., Nakanishi K., Oltz E., and Usherwood P.N. Proc. Natl. Acad. Sci. U.S.A. 85 (1988) 4910
61. Aramaki Y., Yasuhara T., Higashijima T., Yoshioka M., Miwa A., Kawai N., and Nakajima T. Proc. Jpn. Acad. Ser. B-Phys. Biol. Sci. 62 (1986) 359
62. Blaschke M., Keller B.U., Rivosecchi R., Hollmann M., Heinemann S., and Konnerth A. Proc. Natl. Acad. Sci. U.S.A. 90 (1993) 6528
63. Herlitze S., Raditsch M., Ruppersberg J.P., Jahn W., Monyer H., Schoepfer R., and Witzemann V. Neuron 10 (1993) 1131
64. Brackley P.T., Bell D.R., Choi S.K., Nakanishi K., and Usherwood P.N. J. Pharmacol. Exp. Ther. 266 (1993) 1573
65. Hume R.I., Dingledine R., and Heinemann S.F. Science 253 (1991) 1028
66. Kromann H., Krikstolaityte S., Andersen A.J., Andersen K., Krogsgaard-Larsen P., Jaroszewski J.W., Egebjerg J., and Stromgaard K. J. Med. Chem. 45 (2002) 5745
67. Nilsen A., and England P.M. J. Am. Chem. Soc. 129 (2007) 4902
68. Washburn M.S., and Dingledine R. J. Pharmacol. Exp. Ther. 278 (1996) 669
69. Keller B.U., Blaschke M., Rivosecchi R., Hollmann M., Heinemann S.F., and Konnerth A. Proc. Natl. Acad. Sci. U.S.A. 90 (1993) 605
70. Price C.J., and Raymond L.A. Mol. Pharmacol. 50 (1996) 1665
71. Blaschke M., Gremmels D., Everts I., Weigand E., Heinemann S.F., Hollmann M., and Keller B.U. Neuropharmacology 36 (1997) 1489
72. Walker C.S., Jensen S., Ellison M., Matta J.A., Lee W.Y., Imperial J.S., Duclos N., Brockie P.J., Madsen D.M., Isaac J.T., Olivera B., and Maricq A.V. Curr. Biol. 19 (2009) 900
73. Tigaret C., and Choquet D. Science 323 (2009) 1295
74. Milstein A.D., and Nicoll R.A. Trends Pharmacol. Sci. 29 (2008) 333
75. Sager C., Tapken D., Kott S., and Hollmann M. Neuroscience 158 (2009) 45
76. Nicoll R.A., Tomita S., and Bredt D.S. Science 311 (2006) 1253
77. Ziff E.B. Neuron 53 (2007) 627
78. Schwenk J., Harmel N., Zolles G., Bildl W., Kulik A., Heimrich B., Chisaka O., Jonas P., Schulte U., Fakler B., and Klocker N. Science 323 (2009) 1313
79. Schmidt C., Klein C., and Hollmann M. J. Mol. Biol. 390 (2009) 182
80. Kott S., Werner M., Korber C., and Hollmann M. J. Neurosci. 27 (2007) 3780
81. Yamazaki M., Ohno-Shosaku T., Fukaya M., Kano M., Watanabe M., and Sakimura K. Neurosci. Res. 50 (2004) 369
82. Priel A., Kolleker A., Ayalon G., Gillor M., Osten P., and Stern-Bach Y. J. Neurosci. 25 (2005) 2682
83. Tomita S., Adesnik H., Sekiguchi M., Zhang W., Wada K., Howe J.R., Nicoll R.A., and Bredt D.S. Nature 435 (2005) 1052
84. Kott S., Sager C., Tapken D., Werner M., and Hollmann M. Neuroscience 158 (2009) 78
85. Menuz K., Stroud R.M., Nicoll R.A., and Hays F.A. Science 318 (2007) 815
86. Tomita S., Sekiguchi M., Wada K., Nicoll R.A., and Bredt D.S. Proc. Natl. Acad. Sci. U.S.A. 103 (2006) 10064
87. Soto D., Coombs I.D., Kelly L., Farrant M., and Cull-Candy S.G. Nat. Neurosci. 10 (2007) 1260
88. Kato A.S., Siuda E.R., Nisenbaum E.S., and Bredt D.S. Neuron 59 (2008) 986
89. Cho C.H., St-Gelais F., Zhang W., Tomita S., and Howe J.R. Neuron 55 (2007) 890
90. Milstein A.D., Zhou W., Karimzadegan S., Bredt D.S., and Nicoll R.A. Neuron 55 (2007) 905
91. Neyton J., and Paoletti P. J. Neurosci. 26 (2006) 1331
92. Bowie D., Lange G.D., and Mayer M.L. J. Neurosci. 18 (1998) 8175
93. Liu L., Wong T.P., Pozza M.F., Lingenhoehl K., Wang Y., Sheng M., Auberson Y.P., and Wang Y.T. Science 304 (2004) 1021
94. Whitesides G.M., and Krishnamurthy V.M. Q. Rev. Biophys. 38 (2005) 385
95. Roth B.L., Sheffler D.J., and Kroeze W.K. Nat. Rev. Drug Disc. 3 (2004) 353
96. National Institute of Neurological Disorders and Stroke (NINDS). Tolerability and Primary Efficacy of CX-516 in Alzheimer's Disease. In: ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US). 2000-[cited 2009 Dec 18]. Available from: http://clinicaltrials.gov/ct2/show/NCT00001662 NLM Identifier: NCT00001662.
97. Teva Global Respiratory Research LLC. Efficacy and Safety of Talampanel as Adjunctive Therapy in Patients With Partial Seizures: A Phase II Clinical Trial. In: ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US). 2000-[cited 2009 Dec 18]. Available from: http://clinicaltrials.gov/ct2/show/NCT00034814 NLM Identifier: NCT00034814.
98. TorreyPines Therapeutics. A Double-Blind, Placebo-Controlled, Parallel Group Multicenter Study to Assess the Safety, Tolerance and Efficacy of a Single Subcutaneous Dose of TEZAMPANEL in Patients With Acute Migraine. In: ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US). 2000-[cited 2009 Dec [18]. Available from: http://clinicaltrials.gov/ct2/show/NCT00567086 NLM Identifier: NCT00567086.
99. Mony L., Kew J.N., Gunthorpe M.J., and Paoletti P. Br. J. Pharmacol. 157 (2009) 1301
100. Brehm L., Greenwood J.R., Sløk F.A., Holm M.M., Nielsen B., Geneser U., Stensbøl T.B., Bräuner-Osborne H., Begtrup M., Egebjerg J., and Krogsgaard-Larsen P. Chirality 16 (2004) 452
101. Sekiguchi M., Takeo J., Harada T., Morimoto T., Kudo Y., Yamashita S., Kohsaka S., and Wada K. Br. J. Pharmacol. 123 (1998) 1294